Skip to search formSkip to main contentSkip to account menu

FK778

Known as: FK 778, FK-778 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Manitimus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
::: Experimental and Clinical Tranplantation :::
Objectives: The contribution of humoral immune response in allograft and xenograft rejection has been clearly demonstrated in… 
2008
2008
Die Wirkung der Immunsuppressiva Tacrolimus, Sirolimus und FK778 auf die akute zelluläre xenogene Abstoßung im konkordanten Kleintiermodell
Diese Doktorarbeit beschaftigt sich mit einer speziellen Phase der xenogenen Abstosung, der akuten zellularen Abstosung. Hierzu… 
2007
2007
Use of tacrolimus, sirolimus, and FK778 in experimental xenotransplantation – a detailed analysis of drug efficacy on cellular and humoral xenorejection
2006
2006
The immunosuppressive drug FK 778 induces regulatory activity in stimulated human CD 4 CD 25 T cells
The induction of transplantation tolerance involves a T-cell–mediated process of immune regulation. In clinical transplantation… 
2006
2006
Systemic FK778 Prolongs Clear Graft Survival in the Rat Keratoplasty Model
2005
2005
FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation
2005
2005
The immunosuppressant FK778 prevents adhesion molecule upregulation and inhibits endothelium-lymphocyte interaction in vitro
2005
2005
The immunosuppressant FK778 shows favourable drug interactions with tacrolimus and mycophenolate mofetil in experimental cardiac transplantation
2003
2003
Leflunomide analogue FK778 is vasculoprotective independent of its immunosuppressive effect: Potential application for restenosis and chronic rejection
2002
2002
Synergistic effects of tacrolimus with FK778 or FK779 in prevention of acute heart allograft rejection in the rat
Objective Tacrolimus (FK506) and Malononitrilamides (MNA) 279 and 715 (FK778 and FK779) were tested for their mono- and…